DOSSIER · UPDATED 18 NOV 2025

CASI Pharmaceuticals

A biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients.

casipharmaceuticals.com ↗Claim this profile

Founded: 1991
Headcount: 49
Open roles: 0
Last raised: Post Ipo Equity · $15M

SECTION I · THE BRIEF

Inside CASI Pharmaceuticals

Brief #45305Updated 18 NOV 2025ROCKVILLEACCELPOST IPO EQUITY

Employbl Dossier

CASI Pharmaceuticals

A biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients.

Founded: 1991
Headcount: 49
Open roles: 0
Last raised: Post Ipo Equity · $15M

Section II · Premium ProfileMembers only

01Engineering interview process at CASI PharmaceuticalsLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open CASI Pharmaceuticals brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

John W Holaday

OPEN ROLES

Hiring at CASI Pharmaceuticals

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $200,380,000

CASI Pharmaceuticals' Investors

CASI Pharmaceuticals Funding Rounds

Post Ipo Equity
$15,000,000
Jun 26, 2024
Post Ipo Equity
$15,000,000
Jun 25, 2024
Post Ipo Equity Investors
Foresite Capital
Venrock Healthcare Capital Partners
Wei-Wu He
Panacea Venture
Post Ipo Equity
$32,500,000
Mar 24, 2021
Post Ipo Equity
$32,500,000
Mar 23, 2021
Post Ipo Equity
$38,000,000
Jul 22, 2020
Post Ipo Equity
$38,000,000
Jul 21, 2020
Post Ipo Equity
$50,000,000
Mar 20, 2018
Post Ipo Equity
$50,000,000
Mar 19, 2018
Post Ipo Equity Investors
IDG Capital
ETP Fund
Robert Duggan
Post Ipo Equity
$2,380,000
Oct 16, 2017
Post Ipo Equity
$2,380,000
Oct 15, 2017
IPO
Unknown
Jun 16, 2014
IPO
Unknown
Jan 1, 2014
Post Ipo Equity
$10,000,000
Jan 23, 2012
Post Ipo Equity
$10,000,000
Jan 22, 2012
Post Ipo Equity Investors
Accel
Emerging Technology Partners
Post Ipo Equity
$2,500,000
Feb 4, 2010
Post Ipo Equity
$2,500,000
Feb 3, 2010
Post Ipo Debt
$20,000,000
Sep 17, 2007
Post Ipo Debt
$20,000,000
Sep 16, 2007
Post Ipo Debt Investors
GE Healthcare Systems
Merrill Lynch
Oxford Finance
Post Ipo Equity
$30,000,000
Feb 13, 2006
Post Ipo Equity
$30,000,000
Feb 12, 2006

Funding info provided by Diffbot.

TAGS

Categorized in

Company Collections

These are collections CASI Pharmaceuticals is a part of. Click on the collection name to view similar companies.

CASI Pharmaceuticals' Investors

CASI Pharmaceuticals' Industries

Medical Organizations

Health Care Companies

Biotechnology Companies

CASI Pharmaceuticals' Tech Stack

LOCATIONS

Where they work

CASI Pharmaceuticals Headquarters Location

9620 Medical Center Drive Suite 300, Rockville, MD, 20850

Loading map…